Bruce Booth - Net Worth and Insider Trading
Bruce Booth Net Worth
The estimated net worth of Bruce Booth is at least $243 Million dollars as of 2024-05-13. Bruce Booth is the Director of Kymera Therapeutics Inc and owns about 5,377,362 shares of Kymera Therapeutics Inc (KYMR) stock worth over $204 Million. Bruce Booth is the Director of Vigil Neuroscience Inc and owns about 5,836,874 shares of Vigil Neuroscience Inc (VIGL) stock worth over $19 Million. Bruce Booth is also the Director of Avrobio Inc and owns about 5,567,289 shares of Avrobio Inc (AVRO) stock worth over $7 Million. Besides these, Bruce Booth also holds Cogent Biosciences Inc (COGT) , Viridian Therapeutics Inc (VRDN) , Magenta Therapeutics Inc (MGTA) . Details can be seen in Bruce Booth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bruce Booth has not made any transactions after 2024-03-15 and currently still holds the listed stock(s).
Transaction Summary of Bruce Booth
Bruce Booth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bruce Booth owns 7 companies in total, including Kymera Therapeutics Inc (KYMR) , Cogent Biosciences Inc (COGT) , and Magenta Therapeutics Inc (MGTA) among others .
Click here to see the complete history of Bruce Booth’s form 4 insider trades.
Insider Ownership Summary of Bruce Booth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KYMR | Kymera Therapeutics Inc | 2024-03-15 | director |
| COGT | Cogent Biosciences Inc | 2018-04-03 | director |
| MGTA | Magenta Therapeutics Inc | 2020-06-29 | director |
 | | 2019-07-19 | director |
| | 2018-02-13 | director |
| | 2015-07-13 | director & 10 percent owner |
| | 2022-01-11 | director |
Bruce Booth Latest Holdings Summary
Bruce Booth currently owns a total of 6 stocks. Among these stocks, Bruce Booth owns 5,377,362 shares of Kymera Therapeutics Inc (KYMR) as of March 15, 2024, with a value of $204 Million and a weighting of 83.7%. Bruce Booth owns 5,836,874 shares of Vigil Neuroscience Inc (VIGL) as of January 11, 2022, with a value of $19 Million and a weighting of 7.62%. Bruce Booth also owns 5,567,289 shares of Avrobio Inc (AVRO) as of July 19, 2019, with a value of $7 Million and a weighting of 2.81%. The other 3 stocks Cogent Biosciences Inc (COGT) , Viridian Therapeutics Inc (VRDN) , Magenta Therapeutics Inc (MGTA) have a combined weighting of 5.86% among all his current holdings.
Latest Holdings of Bruce Booth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics Inc | 2024-03-15 | 5,377,362 | 37.90 | 203,802,020 |
| VIGL | Vigil Neuroscience Inc | 2022-01-11 | 5,836,874 | 3.18 | 18,561,259 |
| AVRO | Avrobio Inc | 2019-07-19 | 5,567,289 | 1.23 | 6,847,765 |
| COGT | Cogent Biosciences Inc | 2018-04-03 | 840,384 | 7.56 | 6,353,303 |
| VRDN | Viridian Therapeutics Inc | 2018-02-13 | 299,579 | 13.90 | 4,164,148 |
| MGTA | Magenta Therapeutics Inc | 2020-06-29 | 5,367,125 | 0.70 | 3,754,841 |
Holding Weightings of Bruce Booth
Bruce Booth Form 4 Trading Tracker
According to the SEC Form 4 filings, Bruce Booth has made a total of 8 transactions in Kymera Therapeutics Inc (KYMR) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Kymera Therapeutics Inc is the sale of 127,543 shares on March 15, 2024, which brought Bruce Booth around $5 Million.
According to the SEC Form 4 filings, Bruce Booth has made a total of 1 transactions in Vigil Neuroscience Inc (VIGL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vigil Neuroscience Inc is the acquisition of 535,000 shares on January 11, 2022, which cost Bruce Booth around $7 Million.
According to the SEC Form 4 filings, Bruce Booth has made a total of 1 transactions in Avrobio Inc (AVRO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Avrobio Inc is the acquisition of 810,811 shares on July 19, 2019, which cost Bruce Booth around $15 Million.
More details on Bruce Booth's insider transactions can be found in the Insider Trading History of Bruce Booth table.Insider Trading History of Bruce Booth
- 1
Bruce Booth Trading Performance
GuruFocus tracks the stock performance after each of Bruce Booth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruce Booth is -2.8%. GuruFocus also compares Bruce Booth's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruce Booth within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bruce Booth's insider trading performs compared to the benchmark.
Performance of Bruce Booth
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.91 | | | | | |
| Relative Return to S&P 500(%) | 8.29 | | | | | |
Bruce Booth Ownership Network
Bruce Booth Owned Company Details
What does Kymera Therapeutics Inc do?
Who are the key executives at Kymera Therapeutics Inc?
Bruce Booth is the director of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include 10 percent owner Atlas Venture Fund X, L.p. , Chief Medical Officer Jared Gollob , and Chief Financial Officer Bruce N. Jacobs .
Kymera Therapeutics Inc (KYMR) Insider Trades Summary
Over the past 18 months, Bruce Booth made 4 insider transaction in Kymera Therapeutics Inc (KYMR) with a net sale of 989,618. Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 862,075 shares made by Atlas Venture Fund X, L.p. , a net sale of 49,881 shares made by Jared Gollob , and a net purchase of 455,112 shares made by Biotechnology Value Fund L P .
In summary, during the past 3 months, insiders sold 846,935 shares of Kymera Therapeutics Inc (KYMR) in total and bought 0 shares, with a net sale of 846,935 shares. During the past 18 months, 1,925,173 shares of Kymera Therapeutics Inc (KYMR) were sold and 455,112 shares were bought by its insiders, resulting in a net sale of 1,470,061 shares.
Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kymera Therapeutics Inc Insider Transactions
Bruce Booth Mailing Address
Above is the net worth, insider trading, and ownership report for Bruce Booth. You might contact Bruce Booth via mailing address: 890 Winter Street, Suite 320, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
